218 related articles for article (PubMed ID: 2459854)
41. Immunomodulation by recombinant interferon-alpha 2 in a phase I trial in patients with lymphoproliferative malignancies.
Ozer H; Gavigan M; O'Malley J; Thompson D; Dadey B; Nussbaum-Blumenson A; Snider C; Rudnick S; Ferraresi R; Norred S
J Biol Response Mod; 1983; 2(6):499-515. PubMed ID: 6607323
[TBL] [Abstract][Full Text] [Related]
42. Interferon therapy in HCV-positive mixed cryoglobulinaemia: viral and host factors contributing to efficacy of the therapy.
Mazzaro C; Carniello GS; Colle R; Doretto P; Mazzi G; Crovatto M; Santini GF; Tulissi P; Gregoretti M; Mazzoran L; Russo A; Silvestri F; Pozzato G
Ital J Gastroenterol Hepatol; 1997 Aug; 29(4):343-50. PubMed ID: 9476189
[TBL] [Abstract][Full Text] [Related]
43. [Clinical use of interferon].
Lauta VM
Clin Ter; 1996; 147(7-8):345-51. PubMed ID: 9118615
[TBL] [Abstract][Full Text] [Related]
44. Phase II clinical trial of combined natural interferon-beta plus recombinant interferon-gamma treatment of chronic hepatitis B.
Musch E; Högemann B; Gerritzen A; Fischer HP; Wiese M; Kruis W; Malek M; Gugler R; Schmidt G; Huchzermeyer H; Gerlach U; Dengler HJ; Sauerbruch T
Hepatogastroenterology; 1998; 45(24):2282-94. PubMed ID: 9951911
[TBL] [Abstract][Full Text] [Related]
45. [Differentiation of human malignant myeloid and lymphoid cells].
Degos L
Nouv Rev Fr Hematol (1978); 1987; 29(1):37-41. PubMed ID: 2438644
[TBL] [Abstract][Full Text] [Related]
46. Sequential treatment of hairy cell leukemia: a new role for interferon.
Golomb HM; Ratain MJ; Vardiman JW
Important Adv Oncol; 1986; ():311-21. PubMed ID: 2454218
[TBL] [Abstract][Full Text] [Related]
47. [Clinical studies on interferon in cancer therapy in Japan].
Ohno R
Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 1):1194-202. PubMed ID: 2437862
[TBL] [Abstract][Full Text] [Related]
48. Interferon therapy of hematologic malignancies.
Foon KA
Cancer Treat Res; 1998; 94():1-21. PubMed ID: 9587679
[No Abstract] [Full Text] [Related]
49. A biological approach to optimize interferon treatment in hairy cell leukemia.
Gastl G; Aulitzky W; Tilg H; Nachbaur K; Troppmair J; Flener R; Huber C
Immunobiology; 1986 Sep; 172(3-5):262-8. PubMed ID: 3804368
[TBL] [Abstract][Full Text] [Related]
50. Role of interferon in clinical practice.
Sréter L; Fehér J
Ther Hung; 1991; 39(4):159-66. PubMed ID: 1725832
[TBL] [Abstract][Full Text] [Related]
51. [Does the Philadelphia chromosome disappear after treatment with interferon?].
Gastaut JA
Presse Med; 1988 Apr; 17(13):639-44. PubMed ID: 2453050
[TBL] [Abstract][Full Text] [Related]
52. Interferon treatment of human neoplasia.
Strander H
Adv Cancer Res; 1986; 46():1-265. PubMed ID: 2425561
[No Abstract] [Full Text] [Related]
53. [Autopsy results of deep mycoses in hematologic neoplasms (1053 patients].
Donhuijsen K; Pfaffenbach B; Samandari S; Leder LD
Mycoses; 1991; 34 Suppl 1():25-7. PubMed ID: 1818257
[TBL] [Abstract][Full Text] [Related]
54. Therapy with interferons in blood diseases.
Polli E; Cortelezzi A
Acta Haematol; 1987; 78 Suppl 1():64-9. PubMed ID: 2449025
[TBL] [Abstract][Full Text] [Related]
55. alpha-Interferon in hematological malignancies.
Giles FJ; Ozer H
Curr Opin Biotechnol; 1991 Dec; 2(6):847-50. PubMed ID: 1367959
[TBL] [Abstract][Full Text] [Related]
56. [Interferons and interferon therapy].
Strander H
Nord Med; 1992; 107(3):70-1. PubMed ID: 1372403
[No Abstract] [Full Text] [Related]
57. Apheresis in hematologic and oncologic disease.
Cohen RJ
Hosp Pract (Off Ed); 1983 Oct; 18(10):199-205. PubMed ID: 6413369
[TBL] [Abstract][Full Text] [Related]
58. Interferon studies in the treatment of patients with leukemia.
Schiffer CA
Semin Oncol; 1991 Oct; 18(5 Suppl 7):1-6. PubMed ID: 1948122
[TBL] [Abstract][Full Text] [Related]
59. [Clinical use of alpha-interferon in onco-hematology: conclusions and prospects].
Bernasconi C
Haematologica; 1990; 75 Suppl 4():82-4. PubMed ID: 2074058
[No Abstract] [Full Text] [Related]
60. 2nd International Congress on Leukemia, Lymphoma and Myeloma.
Arat M; Ozsan GH; Yenerel MN; Cetin M; Ozcan M
Expert Rev Hematol; 2009 Oct; 2(5):509-12. PubMed ID: 21083016
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
